Current Status and Growth of Nuclear Theranostics in Singapore / 대한핵의학회잡지
Korean Journal of Nuclear Medicine
;
: 96-101, 2019.
Article
in English
| WPRIM
| ID: wpr-786463
ABSTRACT
The concept of theranostics, where individual patient-level biological information is used to choose the optimal therapy for that individual, has become more popular in the modern era of ‘personalised’ medicine. With the growth of theranostics, nuclear medicine as a specialty is uniquely poised to grow along with the ever-increasing number of concepts combining imaging and therapy. This special report summarises the status and growth of Theranostic Nuclear Medicine in Singapore.We will cover our experience with the use of radioiodine, radioiodinated metaiodobenzylguanidine, peptide receptor radionuclide therapy, prostate specific membrane antigen radioligand therapy, radium-223 and yttrium-90 selective internal radiation therapy.We also include a section on our radiopharmacy laboratory, crucial to our implementation of theranostic principles. Radionuclide theranostics has seen tremendous growth and we hope to be able to grow alongside to continue to serve the patients in Singapore and in the region.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Prostate
/
Singapore
/
Yttrium
/
Radium
/
Receptors, Peptide
/
Hope
/
Theranostic Nanomedicine
/
Lutetium
/
Membranes
/
Nuclear Medicine
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Korean Journal of Nuclear Medicine
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS